ALK Expression Defines a Distinct Group of T/Null Lymphomas (“ALK Lymphomas”) with a Wide Morphological Spectrum-Reference-Cited by-同舟云学术

ALK Expression Defines a Distinct Group of T/Null Lymphomas (“ALK Lymphomas”) with a Wide Morphological Spectrum

Published:1998-09 Issue:3 Volume:153 Page:875-886
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Falini Brunangelo,Bigerna Barbara,Fizzotti Marco,Pulford Karen,Pileri Stefano A.,Delsol Georges,Carbone Antonino,Paulli Marco,Magrini Umberto,Menestrina Fabio,Giardini Roberto,Pilotti Silvana,Mezzelani Alessandra,Ugolini Barbara,Billi Monia,Pucciarini Alessandra,Pacini Roberta,Pelicci Pier-Giuseppe,Flenghi Leonardo

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference53 articles.

1. The expression of Hodgkin's disease associated Ki-1 antigen in reactive and neoplastic lymphoid tissues: evidence that Sternberg-Reed cells and histiocytic malignancies are derived from activated lymphoid cells;Stein;Blood,1985

2. CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy;Falini;Blood,1995

3. Primary Ki-1 positive anaplastic large cell lymphoma: a distinct clinicopathologic entity;Kadin;Ann Oncol,1994

4. Anaplastic large cell lymphoma: clinical and prognostic evaluation of 90 adult patients;Zinzani;J Clin Oncol,1996

5. CD30-positive large cell lymphomas (Ki-1 lymphoma) are associated with a chromosomal translocation involving 5q35;Mason;Br J Haematol,1990

Cited by 220 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anaplastic Lymphoma Kinase (ALK) in Posterior Cranial Fossa Tumors: A Scoping Review of Diagnostic, Prognostic, and Therapeutic Perspectives;Cancers;2024-02-02

2. Variant ALK‐fusion positive anaplastic large cell lymphoma (ALCL): A population‐based paediatric study of the NHL‐BFM study group;British Journal of Haematology;2024-01-26

3. Pathobiology of nodal peripheral T-cell lymphomas: current understanding and future directions;Haematologica;2023-11-21

4. Anaplastic lymphoma kinase inhibitors—a review of anticancer properties, clinical efficacy, and resistance mechanisms;Frontiers in Pharmacology;2023-10-25

5. Diagnosis and Molecular Pathology of Lymphoblastic Leukemias and Lymphomas in the Era of Genomics and Precision Medicine: Historical Evolution and Current Concepts—Part 3: Mature Leukemias/Lymphomas;Lymphatics;2023-08-01